← FDA Drug Approvals (Drugs@FDA)
MOMETASONE FUROATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2024-03-18
Drug application
- FDA Application #
ANDA215878- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MOMETASONE FUROATE
- Generic name
- MOMETASONE FUROATE MONOHYDRATE
- Active ingredients
- MOMETASONE FUROATE
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA
- Manufacturer
- Aurobindo Pharma Limited
- First approval
- 2024-03-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown